Stock listing

Stockholm:ATORX Alligator Bioscience AB Aktie

Home listing (Stockholm) of Alligator Bioscience AB

Follow Alligator Bioscience AB into a list and get an email when it puts out news.

Share price · OMXSTO:ATORX

0.0087 SEK +0.0001 (+1.2%)

Close on Nov 18, 2026

Past year -99.2% · daily closes, Nov 18, 2025 – Nov 18, 2026, adjusted for splits
Day range
0.0086 – 0.0091 SEKNov 18, 2026
Volume
10.15M sharesNov 18, 2026
Market cap
31.04M SEKAt the close on Nov 18, 2026 · price × 3.57B shares outstanding
52-week range
0.0083 – 1.1298 SEKLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
Traded on an average day
571,349 SEKMedian day 16.84M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026
Alligator Bioscience AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:ATORX · Home0.0087 SEK+0.0001 (+1.2%)10,154,9240.00860.00910.00860.0086Close on Nov 18, 2026
Frankfurt:7AL0€0.0001 EUR0.0000 (0.0%)—€0.0001€0.0001€0.0001€0.0001Close on Nov 18, 2026

Daily closes

Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OMXSTO:ATORX · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.0087+0.0001+1.2%0.00860.00910.008610,154,924
0.0086-0.0002-2.3%0.00880.00900.008312,239,481
0.0088-0.0003-3.3%0.00930.01000.008734,118,189
0.00910.00000.0%0.00910.00970.00899,658,943
0.0091-0.0007-7.1%0.01000.01010.008943,339,388
0.0098-0.0003-3.0%0.01000.01010.009618,387,106
0.0101-0.0003-2.9%0.01070.01070.009940,957,360
0.0104-0.0003-2.8%0.01080.01100.010356,605,464
0.0107-0.0004-3.6%0.01120.01130.010287,815,616
0.0111-0.0014-11.2%0.01280.01290.0107141,789,162
0.0125+0.0026+26.3%0.01870.01990.0117535,017,989
0.0099-0.0001-1.0%0.01010.01010.00986,107,124
0.0100-0.0001-1.0%0.01000.01040.009720,770,846
0.0101-0.0010-9.0%0.01110.01110.009746,645,799
0.0111+0.0004+3.7%0.01080.01140.010351,704,703
0.0107+0.0006+5.9%0.01010.01070.009832,065,794
0.0101-0.0005-4.7%0.01080.01090.0096124,637,325
0.0106-0.0002-1.9%0.01090.01110.009963,474,371
0.0108-0.0008-6.9%0.01210.01260.010832,693,949
0.0116-0.0010-7.9%0.01290.01290.011444,026,390
0.0126-0.0006-4.5%0.01330.01340.01266,815,229
0.0132+0.0002+1.5%0.01280.01330.012622,150,075
0.0130-0.0004-3.0%0.01350.01350.012712,509,086
0.0134-0.0013-8.8%0.01500.01520.013075,997,507
0.0147+0.0002+1.4%0.01460.02160.014592,561,964
0.0145-0.0008-5.2%0.01550.01550.014511,712,187
0.0153-0.0008-5.0%0.01570.01610.015310,382,603
0.0161-0.0012-6.9%0.01730.01730.015329,633,664
0.0173+0.0001+0.6%0.01750.01770.016010,196,727
0.0172-0.0008-4.4%0.01880.01890.01725,124,857
0.0180-0.0013-6.7%0.01990.02050.018015,525,797
0.0193-0.0004-2.0%0.02070.02070.01921,612,698
0.0197-0.0003-1.5%0.02000.02010.01903,543,122
0.0200-0.0009-4.3%0.02090.02180.019416,005,292
0.0209-0.0012-5.4%0.02280.02280.02014,916,576
0.0221-0.0009-3.9%0.02320.02450.021715,111,387
0.0230+0.0032+16.2%0.01980.02480.019835,046,932
0.0198-0.0004-2.0%0.02050.02050.01952,657,451
0.0202-0.0010-4.7%0.02130.02130.01967,350,637
0.0212+0.0002+1.0%0.02100.02160.02024,516,403
0.0210-0.0020-8.7%0.02310.02310.020118,977,716
0.0230-0.0006-2.5%0.02390.02390.02148,263,185
0.0236+0.0003+1.3%0.02400.02450.02253,163,888
0.0233+0.0009+4.0%0.02210.02440.021410,361,355
0.0224+0.0009+4.2%0.02150.02340.020810,024,366
0.0215-0.0013-5.7%0.02290.02350.02124,188,776
0.0228-0.0002-0.9%0.02310.02350.02245,365,387
0.0230-0.0010-4.2%0.02400.02450.02274,060,089
0.02400.00000.0%0.02470.02470.022216,793,301
0.0240-0.0020-7.7%0.02650.02650.024012,644,828
0.0260+0.0010+4.0%0.02570.02690.025122,424,924
0.0250-0.0007-2.7%0.02600.02720.024724,731,673
0.0257-0.0007-2.7%0.02640.02780.025117,206,620
0.0264-0.0009-3.3%0.02760.03120.024536,082,633
0.0273-0.0036-11.7%0.03050.03900.0251119,458,977
0.0309+0.0009+3.0%0.03200.03290.030113,357,519
0.0300-0.0020-6.3%0.03110.03270.029016,841,369
0.0320-0.0026-7.5%0.03440.03460.030020,641,711
0.0346+0.0063+22.3%0.02900.03600.029058,741,072
0.0283-0.0021-6.9%0.03040.03100.028313,187,890
0.0304-0.0007-2.3%0.03100.03100.02973,782,883
0.0311+0.0008+2.6%0.03200.03200.029812,461,341
0.0303-0.0014-4.4%0.03270.03390.029118,688,403
0.0317+0.0017+5.7%0.03040.03680.029037,615,807
0.0300-0.0031-9.4%0.03310.03400.029428,377,503

Splits

4 splits since 2021 · OMXSTO:ATORX · every price before a split is adjusted for it

DayRatioWhat
1-for-1000Consolidation
33-for-20Split
1.0915-for-1Split
49-for-47Split
Ticker
Stockholm:ATORX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stockholm
Currency
SEK

What changed lately

Calls

Replays

  • Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call

    Wed, Aug 26, 2026 · 9:00 AM ET

    Watch Transcript
  • Alligator Bioscience (Stockholm:ATORX) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 7:00 AM ET

    Watch Transcript
  • Alligator Bioscience (Stockholm:ATORX) Q4 2025 Earnings Call

    Thu, Feb 12, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

All Alligator Bioscience AB news

Financings

  • Rights offering of units of ordinary shares and warrants series TO 15 and TO 16

    Sep 22, 2026 · US$5.97M

    Closed: SEK 58.8M raised · SEK 0.04 a unit · each unit consists of two ordinary shares, one warrant series TO 15 and one warrant… · APREA Partners AB +1

    Dealers: APREA Partners AB, Vator Securities AB

    Buyers: Roxette Photo S.A. (part of subscription undertakings totaling SEK 2 million); Søren Bregenholt (part of subscription undertakings totaling SEK 2 million); Vator Securities AB (guarantee commitments totaling SEK 56.8 million together with Mangold); Mangold Fondkommission AB (guarantee commitments totaling SEK 56.8 million together with Vator Securities)

    Insiders: Existing shareholders including CEO Søren Bregenholt have entered into subscription undertakings totaling SEK 2 million

    Use of proceeds: Repayment of bridge loans of SEK 19 million

    Announced Jul 23, 2026 · Update Aug 26, 2026 · Update Aug 31, 2026 · Closed Sep 22, 2026

  • Warrant exercise of ordinary shares via exercise of warrants series TO 14

    Feb 27, 2026 · US$5.43M

    Announced: about SEK 49M · SEK 0.2 a share

    Use of proceeds: General corporate purposes and loan repayment

    Announced Feb 27, 2026

  • Rights offering of units, each of two ordinary shares and one warrant series TO 14

    Dec 19, 2025 · US$9.81M

    Update: about SEK 91M · SEK 0.4 a unit · one (1) warrant series TO 14 per unit · Vator Securities AB +1

    Dealers: Vator Securities AB (lead), Setterwalls Advokatbyrå AB

    Buyers: Fenja Capital (guarantee commitment of SEK 30 million); Hans-Peter Ostler, Søren Bregenholt, Johan Giléus (intend to subscribe pro rata, approximately SEK 0.7 million in total); Roxette Photo SA (Additional subscription undertaking, part of approximately SEK 5.4 million in total); Magnus Petersson (Additional subscription undertaking, part of approximately SEK 5.4 million in total); HDF Impact BV (Top guarantee commitment, part of SEK 12.5 million in total)

    Insiders: Subscription undertakings from existing major shareholders and certain members of the Board of Directors and management totalling approximately SEK 6 million

    Use of proceeds: Issue costs, repayment of bridge loans and repayment of part of the outstanding loan to Fenja Capital II A/S

    Announced Oct 22, 2025 · Update Oct 22, 2025 · Update Oct 23, 2025 · Update Nov 25, 2025 · Update Dec 1, 2025 · Update Dec 3, 2025 · Update Dec 19, 2025

  • Warrant exercise of ordinary shares via exercise of warrants series TO 13

    Sep 17, 2025

    Closed: SEK 28.1M in the latest tranche · SEK 3.12 a share · Vator Securities

    Dealers: Vator Securities

    Insiders: Chairman of the Board, CEO and CFO intend to exercise all of their TO 13, totalling approximately SEK 0.2 million

    Use of proceeds: Loan repayment to Fenja Capital (50% of net proceeds) and general corporate purposes, supporting mitazalimab toward Phase 3 and a partnership

    Announced Aug 27, 2025 · Update Sep 8, 2025 · Closed Sep 16, 2025 · Closed Sep 17, 2025

  • Warrant exercise of ordinary shares (directed issue to top guarantors of warrants series TO 12)

    May 26, 2025

    Closed: SEK 61.5M raised · SEK 3.68 a share · Vator Securities

    Dealers: Vator Securities

    Buyers: Roxette Photo SA (Subscription undertaking, part of approximately SEK 16.2 million in total undertakings); Fenja Capital II A/S (1,810,425 ordinary shares for SEK 6,662,364.00); Birger Jarl 2 AB (125,209 ordinary shares for SEK 460,769.12); Consentia Group AB (125,209 ordinary shares for SEK 460,769.12); Johan Carlström (125,209 ordinary shares for SEK 460,769.12); Ghanem Chouha (75,125 ordinary shares for SEK 276,460.00); Tony Chouha (75,125 ordinary shares for SEK 276,460.00); Ulti AB (75,125 ordinary shares for SEK 276,460.00); Bohr Invest AB (75,125 ordinary shares for SEK 276,460.00); Niclas Löwgren (62,604 ordinary shares for SEK 230,382.72); Stefan Hansson (62,604 ordinary shares for SEK 230,382.72); Great Ventures & Consulting GCV AB (62,604 ordinary shares for SEK 230,382.72); Axel Lindberg (56,344 ordinary shares for SEK 207,345.92)

    Insiders: The Chairman of the Board, CEO and CFO gave subscription undertakings, part of approximately SEK 16.2 million in total undertakings

    Use of proceeds: General corporate purposes, developing mitazalimab toward Phase 3, securing a mitazalimab partnership, and loan repayment

    Announced Apr 28, 2025 · Update May 9, 2025 · Update May 20, 2025 · Closed May 26, 2025

Read by 6ix AI from the company's releases

Decks

Alligator Bioscience AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
35 in the last 12 months · 77 in all · newest Nov 13, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Aug 26, 2026
Decks
17 decks · latest September 2026

Where Alligator Bioscience AB is listed

ListingExchangeCountryCurrency
Stockholm:ATORX · Home listing · This pageStockholmSwedenSEK
LSE:0RK9LSEUnited KingdomSEK
LS Exchange:A41BEDLS ExchangeGermanyEUR
Lang & Schwarz:A41BEDLang & SchwarzGermanyEUR
Aquis:ATORXSAquisUnited KingdomSEK
Frankfurt:7AL0FrankfurtGermanyEUR
Aquis:ATORXSAquisUnited KingdomSEK
Stuttgart:7AL0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Alligator Bioscience AB.